Skip to main content
HERON THERAPEUTICS, INC. /DE/ logo

HERON THERAPEUTICS, INC. /DE/ — Investor Relations & Filings

Ticker · HRTX ISIN · US4277461020 LEI · 549300DR2I1DOPD2IX53 US Manufacturing
Filings indexed 1,022 across all filing types
Latest filing 2026-04-30 Annual Report
Country US United States of America
Listing US HRTX

About HERON THERAPEUTICS, INC. /DE/

https://www.herontx.com/

Heron Therapeutics, Inc. is a commercial-stage biotechnology company focused on developing and commercializing therapies to address unmet medical needs in acute care and oncology. The company utilizes its proprietary drug delivery technologies to create novel, best-in-class treatments. Its product portfolio is designed to improve the lives of patients by providing solutions for significant medical issues, including postoperative pain management, with an aim to reduce opioid reliance, as well as managing postoperative and chemotherapy-induced nausea and vomiting.

Recent filings

Filing Released Lang Actions
ARS - HERON THERAPEUTICS, INC. /DE/ (0000818033) (Filer)
Annual Report
2026-04-30 English
DEF 14A - HERON THERAPEUTICS, INC. /DE/ (0000818033) (Filer)
Proxy Solicitation & Information Statement
2026-04-30 English
8-K - HERON THERAPEUTICS, INC. /DE/ (0000818033) (Filer)
Regulatory Filings
2026-04-06 English
10-K - HERON THERAPEUTICS, INC. /DE/ (0000818033) (Filer)
Annual Report FY 2025
2026-02-26 English
8-K - HERON THERAPEUTICS, INC. /DE/ (0000818033) (Filer)
Regulatory Filings
2026-02-26 English
4 Filing
Director's Dealing
2026-02-03 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.